Details for New Drug Application (NDA): 020120
✉ Email this page to a colleague
The generic ingredient in ALLERNAZE is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Seventy-one suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
Summary for 020120
Tradename: | ALLERNAZE |
Applicant: | Lupin Atlantis |
Ingredient: | triamcinolone acetonide |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 020120
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SPRAY, METERED;NASAL | Strength | 0.05MG/SPRAY | ||||
Approval Date: | Feb 4, 2000 | TE: | RLD: | No |
Complete Access Available with Subscription